<VariationArchive RecordType="classified" VariationID="17819" VariationName="NM_000103.4(CYP19A1):c.1224del (p.Lys409fs)" VariationType="Deletion" Accession="VCV000017819" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-04-25" DateCreated="2015-05-13" MostRecentSubmission="2015-05-13">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="32858" VariationID="17819">
      <GeneList>
        <Gene Symbol="CYP19A1" FullName="cytochrome P450 family 19 subfamily A member 1" GeneID="1588" HGNC_ID="HGNC:2594" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>15q21.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="51208057" stop="51338596" display_start="51208057" display_stop="51338596" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="15" Accession="NC_000015.9" start="51500253" stop="51630794" display_start="51500253" display_stop="51630794" Strand="-" />
          </Location>
          <OMIM>107910</OMIM>
        </Gene>
        <Gene Symbol="MIR4713HG" FullName="MIR4713 host gene" GeneID="109729174" HGNC_ID="HGNC:53124" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>15q21.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="51037488" stop="51293912" display_start="51037488" display_stop="51293912" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="PIRC66" FullName="piwi-interacting RNA cluster 66" GeneID="100313865" HGNC_ID="HGNC:37570" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>15q21.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="51037584" stop="51322397" display_start="51037584" display_stop="51322397" Strand="+" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NM_000103.4(CYP19A1):c.1224del (p.Lys409fs)</Name>
      <CanonicalSPDI>NC_000015.10:51212358:GGGG:GGG</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>15q21.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="51212359" stop="51212359" display_start="51212359" display_stop="51212359" variantLength="1" positionVCF="51212358" referenceAlleleVCF="TG" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="15" Accession="NC_000015.9" start="51504556" stop="51504556" display_start="51504556" display_stop="51504556" variantLength="1" positionVCF="51504555" referenceAlleleVCF="TG" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>K409fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000015.10" sequenceAccession="NC_000015" sequenceVersion="10" change="g.51212362del" Assembly="GRCh38">
            <Expression>NC_000015.10:g.51212362del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000015.9" sequenceAccession="NC_000015" sequenceVersion="9" change="g.51504559del" Assembly="GRCh37">
            <Expression>NC_000015.9:g.51504559del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007982.1" sequenceAccession="NG_007982" sequenceVersion="1" change="g.131240del">
            <Expression>NG_007982.1:g.131240del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000103.4" sequenceAccession="NM_000103" sequenceVersion="4" change="c.1224del" MANESelect="true">
            <Expression>NM_000103.4:c.1224del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000094.2" sequenceAccession="NP_000094" sequenceVersion="2" change="p.Lys409fs">
            <Expression>NP_000094.2:p.Lys409fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001347248.1" sequenceAccession="NM_001347248" sequenceVersion="1" change="c.1224del">
            <Expression>NM_001347248.1:c.1224del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001334177.1" sequenceAccession="NP_001334177" sequenceVersion="1" change="p.Lys409fs">
            <Expression>NP_001334177.1:p.Lys409fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001347249.2" sequenceAccession="NM_001347249" sequenceVersion="2" change="c.1224del">
            <Expression>NM_001347249.2:c.1224del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001334178.1" sequenceAccession="NP_001334178" sequenceVersion="1" change="p.Lys409fs">
            <Expression>NP_001334178.1:p.Lys409fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001347250.2" sequenceAccession="NM_001347250" sequenceVersion="2" change="c.1224del">
            <Expression>NM_001347250.2:c.1224del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001334179.1" sequenceAccession="NP_001334179" sequenceVersion="1" change="p.Lys409fs">
            <Expression>NP_001334179.1:p.Lys409fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001347251.2" sequenceAccession="NM_001347251" sequenceVersion="2" change="c.1224del">
            <Expression>NM_001347251.2:c.1224del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001334180.1" sequenceAccession="NP_001334180" sequenceVersion="1" change="p.Lys409fs">
            <Expression>NP_001334180.1:p.Lys409fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001347252.2" sequenceAccession="NM_001347252" sequenceVersion="2" change="c.1224del">
            <Expression>NM_001347252.2:c.1224del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001334181.1" sequenceAccession="NP_001334181" sequenceVersion="1" change="p.Lys409fs">
            <Expression>NP_001334181.1:p.Lys409fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001347253.2" sequenceAccession="NM_001347253" sequenceVersion="2" change="c.1224del">
            <Expression>NM_001347253.2:c.1224del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001334182.1" sequenceAccession="NP_001334182" sequenceVersion="1" change="p.Lys409fs">
            <Expression>NP_001334182.1:p.Lys409fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001347254.2" sequenceAccession="NM_001347254" sequenceVersion="2" change="c.1224del">
            <Expression>NM_001347254.2:c.1224del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001334183.1" sequenceAccession="NP_001334183" sequenceVersion="1" change="p.Lys409fs">
            <Expression>NP_001334183.1:p.Lys409fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001347255.2" sequenceAccession="NM_001347255" sequenceVersion="2" change="c.1224del">
            <Expression>NM_001347255.2:c.1224del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001334184.1" sequenceAccession="NP_001334184" sequenceVersion="1" change="p.Lys409fs">
            <Expression>NP_001334184.1:p.Lys409fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001347256.2" sequenceAccession="NM_001347256" sequenceVersion="2" change="c.1224del">
            <Expression>NM_001347256.2:c.1224del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001334185.1" sequenceAccession="NP_001334185" sequenceVersion="1" change="p.Lys409fs">
            <Expression>NP_001334185.1:p.Lys409fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_031226.3" sequenceAccession="NM_031226" sequenceVersion="3" change="c.1224del">
            <Expression>NM_031226.3:c.1224del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_112503.1" sequenceAccession="NP_112503" sequenceVersion="1" change="p.Lys409fs">
            <Expression>NP_112503.1:p.Lys409fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA213004" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="107910.0005" DB="OMIM" />
        <XRef Type="rs" ID="786205108" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000103.4(CYP19A1):c.1224del (p.Lys409fs) AND Aromatase deficiency" Accession="RCV000019397" Version="24">
        <ClassifiedConditionList TraitSetID="5883">
          <ClassifiedCondition DB="MedGen" ID="C1960539">Aromatase deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="1997-06-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="1997-06-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2015-05-13" MostRecentSubmission="2015-05-13">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">9177373</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="5883" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="12891" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Aromatase deficiency</ElementValue>
                <XRef ID="MONDO:0013301" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Increased aromatase activity</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Pseudohermaphroditism, female, due to placental aromatase deficiency</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="365" />
                <XRef ID="365" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Aromatase deficiency is a rare autosomal recessive disorder in which individuals cannot synthesize endogenous estrogens. If a fetus lacks aromatase activity, dehydroepiandrosterone sulfate produced by the fetal adrenal glands cannot be converted to estrogen by the placenta, and is converted to testosterone peripherally and results in virilization of both fetus and mother. Virilization manifests as pseudohermaphroditism in female infants, with hirsutism and acne in the mother; the maternal indicators resolve following delivery. Affected females are usually diagnosed at birth because of the pseudohermaphroditism. Cystic ovaries and delayed bone maturation can occur during childhood and adolescence in these girls, who present at puberty with primary amenorrhea, failure of breast development, virilization, and hypergonadotropic hypogonadism. Affected males do not present with obvious defects at birth. Their clinical symptoms include tall stature, delayed skeletal maturation, delayed epiphyseal closure, bone pain, eunuchoid body proportions, and excess adiposity. Estrogen replacement therapy reverses the symptoms in males and females (summary by Jones et al., 2007).</Attribute>
                <XRef Type="MIM" ID="613546" DB="OMIM" />
              </AttributeSet>
              <XRef ID="91" DB="Orphanet" />
              <XRef ID="C1960539" DB="MedGen" />
              <XRef ID="MONDO:0013301" DB="MONDO" />
              <XRef Type="MIM" ID="613546" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="39687" SubmissionDate="2015-05-08" DateLastUpdated="2015-05-13" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="107910.0005_AROMATASE DEFICIENCY" title="CYP19A1, 1-BP DEL, C, CODON 408_AROMATASE DEFICIENCY" />
        <ClinVarAccession Accession="SCV000039687" DateUpdated="2015-05-13" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1997-06-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Mullis et al. (1997) reported a female with aromatase deficiency (613546) who was compound heterozygous for 2 point mutations in the CYP19 gene. The maternal allele had a basepair (C) deletion at codon 408 (CCC) that caused a frameshift resulting in a nonsense codon 111 bp (37 amino acids) 3-prime to the deletion. The paternal allele had a G-to-A transition at the 5-prime splice site (conserved GT to AT) between exon and intron 3 (IVS3+1G-A; 107910.0006). This mutation ignores the 5-prime splice site resulting in a read-through to a stop codon 3 bp downstream. Aromatase deficiency was suspected because of the marked prepartum virilization in the mother, and the diagnosis was confirmed shortly after birth. Extremely low levels of serum estrogens were found in contrast to high levels of androgens. Ultrasonographic studies of the child showed persistently enlarged ovaries containing numerous large cysts and normal-appearing large tertiary follicles at 2 years of age. Basal and GNRH-induced FSH levels remained strikingly elevated. Low-dose estradiol given for 50 days at the age of 3.5 years resulted in normalization of serum gonadotropin levels, regression of ovarian size, and increase of whole body and lumbar spine bone mineral density. The FSH levels and ovarian size returned to pretreatment levels 150 days after cessation of estradiol therapy.</Attribute>
              <Citation>
                <ID Source="PubMed">9177373</ID>
              </Citation>
              <XRef DB="OMIM" ID="613546" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CYP19A1" />
          </GeneList>
          <Name>CYP19A1, 1-BP DEL, C, CODON 408</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, C, CODON 408</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="107910.0005" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">AROMATASE DEFICIENCY</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="39687" TraitType="Disease" MappingType="Name" MappingValue="AROMATASE DEFICIENCY" MappingRef="Preferred">
        <MedGen CUI="C1960539" Name="Aromatase deficiency" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

